Multicentre, Adaptive, Double-Blind, Three-Arm, Placebo-Controlled, Noninferiority Trial Examining Antimicrobial Prophylaxis Duration in Cardiac Surgery: CALIPSO Trial

T. Peel,P. Myles,J. Smith, D. McGiffin, S. Marasco,A. Forbes, D. Pilcher, D. Petrie, A. Stewardson,A. Peleg, S. Forster, J. Wisniewski, P. Russo, S. Astbury, P. Druce, K. Goulding, J. Roney

Heart, Lung and Circulation(2023)

引用 0|浏览0
暂无评分
摘要
Administration of antibiotics before incision ("surgical antimicrobial prophylaxis") is a critical infection prevention strategy in cardiac surgery. Extending doses of prophylaxis into the postoperative period is common practice in cardiac surgery; however, the benefit has not been clearly established and may drive emergence of antimicrobial resistance and lead to patient harm. Recent World Health Organization guidelines have recommended that prophylaxis be limited to the intraoperative period only for all surgical procedures, but potential benefits with extending prophylaxis postoperatively in cardiac surgery were noted. The efficacy, safety, and microbiome impact of differing durations of surgical antimicrobial prophylaxis in cardiac surgery have not been established.
更多
查看译文
关键词
antimicrobial prophylaxis duration,cardiac surgery,noninferiority trial,double-blind,three-arm,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要